As shown in Figures 2C,D, the breast cancer risk alleles CCL5 rs2280789-G and CCL5 rs2107538-T were highly associated in a dose-dependent manner with low levels of CCL5 in sera of patients with breast cancer (all patients without subtype stratification). The gene discussed is CCL5; the disease is breast cancer.